Literature DB >> 23307425

Clinical outcomes and management of inflammatory bowel disease in the older patient.

Christina Y Ha1, Seymour Katz.   

Abstract

The management of inflammatory bowel disease in the older patient extends beyond the gastrointestinal tract. Pre-existing comorbidities, polypharmacy, functional status and physical reserve can impact disease course, response to therapy and quality of life. Current therapeutic endpoints may not be as immediately applicable to the older IBD patient at higher risk for adverse outcomes. This review focuses on the latest studies addressing the natural history, clinical course and therapeutic outcomes among the older IBD cohort.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23307425     DOI： 10.1007/s11894-012-0310-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  49 in total

Review 1.  AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

Authors:  Francis A Farraye; Robert D Odze; Jayne Eaden; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2010-02       Impact factor: 22.682

2.  Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease.

Authors:  Gilaad G Kaplan; James Hubbard; Remo Panaccione; Abdel Aziz M Shaheen; Hude Quan; Geoffrey C Nguyen; Elijah Dixon; Subrata Ghosh; Robert P Myers
Journal:  Arch Surg       Date:  2011-08

3.  How much can elderly patients tell us about their medications?

Authors:  H al Mahdy; D G Seymour
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

4.  Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley
Journal:  J Crohns Colitis       Date:  2012-03-21       Impact factor: 9.071

5.  Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a Surveillance Epidemiology and End Results Medicare study.

Authors:  Susan L Gearhart; Hari Nathan; Timothy M Pawlik; Elizabeth Wick; Jonathan Efron; Andrew D Shore
Journal:  Dis Colon Rectum       Date:  2012-03       Impact factor: 4.585

6.  Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

7.  Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis.

Authors:  Jessica Widdifield; Sasha Bernatsky; J Michael Paterson; Nadia Gunraj; J Carter Thorne; Janet Pope; Alfred Cividino; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

8.  Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.

Authors:  Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

9.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; E L McGinley; D G Binion
Journal:  Gut       Date:  2007-09-28       Impact factor: 23.059

10.  Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.

Authors:  J E Baars; E J Kuipers; M van Haastert; J J Nicolaï; A C Poen; C J van der Woude
Journal:  J Gastroenterol       Date:  2012-05-25       Impact factor: 7.527
View more
  9 in total

1.  Common GI Drug Interactions in the Elderly.

Authors:  Marina Kim; Aamir Dam; Jesse Green
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

2.  Management of IBD in the Elderly Patient With Cancer.

Authors:  Garrett Lawlor; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

3.  Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.

Authors:  Matthew Geisz; Christina Ha; Michael D Kappelman; Christopher F Martin; Wenli Chen; Kristen Anton; Robert S Sandler; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2016-06       Impact factor: 5.325

Review 4.  Management of inflammatory bowel disease in the elderly: do biologicals offer a better alternative?

Authors:  Christina Ha; Seymour Katz
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

Review 5.  The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future Perspectives.

Authors:  Ian Arnott; Gerhard Rogler; Jonas Halfvarson
Journal:  Inflamm Intest Dis       Date:  2018-06-26

Review 6.  Healthcare maintenance in elderly patients with inflammatory bowel disease.

Authors:  Manish P Shrestha; Joannie Ruel; Sasha Taleban
Journal:  Ann Gastroenterol       Date:  2017-02-17

7.  Malassezia in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis.

Authors:  Qiyu Yang; Jing Ouyang; Damao Pi; Li Feng; Jiadan Yang
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

Review 8.  Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Elizabeth S John; Kristina Katz; Mark Saxena; Sita Chokhavatia; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2016-09

9.  Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.

Authors:  N A Kennedy; R Kalla; B Warner; C J Gambles; R Musy; S Reynolds; R Dattani; H Nayee; R Felwick; R Harris; S Marriott; S M Senanayake; C A Lamb; H Al-Hilou; D R Gaya; P M Irving; J Mansfield; M Parkes; T Ahmad; J R F Cummings; I D Arnott; J Satsangi; A J Lobo; M Smith; J O Lindsay; C W Lees
Journal:  Aliment Pharmacol Ther       Date:  2014-10-06       Impact factor: 8.171
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.